EP1545596A4 - Utilisation de modulateurs du recepteur h4 de l'histamine pour le traitement des allergies et de l'asthme - Google Patents
Utilisation de modulateurs du recepteur h4 de l'histamine pour le traitement des allergies et de l'asthmeInfo
- Publication number
- EP1545596A4 EP1545596A4 EP03794649A EP03794649A EP1545596A4 EP 1545596 A4 EP1545596 A4 EP 1545596A4 EP 03794649 A EP03794649 A EP 03794649A EP 03794649 A EP03794649 A EP 03794649A EP 1545596 A4 EP1545596 A4 EP 1545596A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- histamine
- allergy
- asthma
- treatment
- receptor modulators
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40873602P | 2002-09-06 | 2002-09-06 | |
US408736P | 2002-09-06 | ||
PCT/US2003/027943 WO2004021999A2 (fr) | 2002-09-06 | 2003-09-05 | Utilisation de modulateurs du récepteur h4 de l'histamine pour le traitement des allergies et de l'asthme |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1545596A2 EP1545596A2 (fr) | 2005-06-29 |
EP1545596A4 true EP1545596A4 (fr) | 2005-12-28 |
Family
ID=31978667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03794649A Withdrawn EP1545596A4 (fr) | 2002-09-06 | 2003-09-05 | Utilisation de modulateurs du recepteur h4 de l'histamine pour le traitement des allergies et de l'asthme |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1545596A4 (fr) |
JP (1) | JP2006510590A (fr) |
AU (1) | AU2003265961A1 (fr) |
CA (1) | CA2497788A1 (fr) |
MX (1) | MXPA05002577A (fr) |
WO (1) | WO2004021999A2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1846409A1 (fr) * | 2004-11-24 | 2007-10-24 | Pfizer Limited | Dérivés d' octahydropyrrolo[3,4-c]pyrrole |
EP1671972A1 (fr) * | 2004-11-24 | 2006-06-21 | Pfizer Limited | Dérivés d' octahydropyrrolo[3,4-c]pyrrole |
WO2007117465A2 (fr) | 2006-03-31 | 2007-10-18 | Abbott Laboratories | Composés d'indazole |
US8492405B2 (en) * | 2006-10-18 | 2013-07-23 | Takeda Pharmaceutical Company Limited | Glucokinase-activating fused heterocyclic compounds and methods of treating diabetes and obesity |
KR100954138B1 (ko) * | 2007-12-31 | 2010-04-20 | 부산대학교 산학협력단 | 지방조직 유래 줄기세포를 함유하는 알레르기 비염 또는천식 예방 및 치료제 |
EP2201982A1 (fr) | 2008-12-24 | 2010-06-30 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Antagonistes du récepteur H4 de l'histamine pour le traitement de troubles vestibulaires |
JP2012102017A (ja) * | 2009-03-03 | 2012-05-31 | Astellas Pharma Inc | インドール化合物 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002072548A2 (fr) * | 2001-03-09 | 2002-09-19 | Ortho-Mcneil Pharmaceutical, Inc. | Composes heterocycliques |
WO2003057919A2 (fr) * | 2001-12-21 | 2003-07-17 | Ortho-Mcneil Pharmaceutical, Inc. | Utilisation de l'antagoniste du recepteur h4 de l'histamine pour traiter les reponses inflammatoires |
WO2004022061A1 (fr) * | 2002-09-06 | 2004-03-18 | Janssen Pharmaceutica, N.V. | Methode de traitement de rhinite allergique |
WO2004022060A2 (fr) * | 2002-09-06 | 2004-03-18 | Janssen Pharmaceutica, N.V. | Composes heterocycliques |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001085786A2 (fr) * | 2000-05-05 | 2001-11-15 | Wyeth | Recepteur a l'histamine h4 humain |
AU2001241713C1 (en) * | 2000-05-31 | 2006-11-30 | Ortho-Mcneil Pharmaceutical, Inc. | DNAs encoding mammalian histamine receptor of the H4 subtype |
GB0101223D0 (en) * | 2001-01-17 | 2001-02-28 | Pfizer Ltd | Histamine receptor antagonists |
-
2003
- 2003-09-05 AU AU2003265961A patent/AU2003265961A1/en not_active Abandoned
- 2003-09-05 WO PCT/US2003/027943 patent/WO2004021999A2/fr not_active Application Discontinuation
- 2003-09-05 MX MXPA05002577A patent/MXPA05002577A/es not_active Application Discontinuation
- 2003-09-05 EP EP03794649A patent/EP1545596A4/fr not_active Withdrawn
- 2003-09-05 JP JP2004534688A patent/JP2006510590A/ja not_active Withdrawn
- 2003-09-05 CA CA002497788A patent/CA2497788A1/fr not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002072548A2 (fr) * | 2001-03-09 | 2002-09-19 | Ortho-Mcneil Pharmaceutical, Inc. | Composes heterocycliques |
WO2003057919A2 (fr) * | 2001-12-21 | 2003-07-17 | Ortho-Mcneil Pharmaceutical, Inc. | Utilisation de l'antagoniste du recepteur h4 de l'histamine pour traiter les reponses inflammatoires |
WO2004022061A1 (fr) * | 2002-09-06 | 2004-03-18 | Janssen Pharmaceutica, N.V. | Methode de traitement de rhinite allergique |
WO2004022060A2 (fr) * | 2002-09-06 | 2004-03-18 | Janssen Pharmaceutica, N.V. | Composes heterocycliques |
Non-Patent Citations (4)
Title |
---|
HOFSTRA C L ET AL: "Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells.", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, vol. 305, no. 3, June 2003 (2003-06-01), pages 1212 - 1221, XP002352480, ISSN: 0022-3565 * |
LIU C ET AL: "Comparison of human, mouse, rat and guinea pig histamine H4 receptors reveals substantial pharmacological species variation", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, AMERICAN SOCIETY FOR PHARMACOLOGY AND, US, vol. 299, no. 1, 2001, pages 121 - 130, XP009013631, ISSN: 0022-3565 * |
O'REILLY M ET AL: "Identification of a histamine H4 receptor of human eosinophils - role in eosinophil chemotaxis", JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH, MARCEL DEKKER, NEW YORK, NY, US, vol. 22, no. 1-4, February 2002 (2002-02-01), pages 431 - 448, XP009047851, ISSN: 1079-9893 * |
THURMOND R L ET AL: "A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, vol. 309, no. 1, 1 April 2004 (2004-04-01), pages 404 - 413, XP002352481, ISSN: 0022-3565 * |
Also Published As
Publication number | Publication date |
---|---|
EP1545596A2 (fr) | 2005-06-29 |
JP2006510590A (ja) | 2006-03-30 |
AU2003265961A1 (en) | 2004-03-29 |
WO2004021999A2 (fr) | 2004-03-18 |
WO2004021999A3 (fr) | 2004-10-07 |
MXPA05002577A (es) | 2005-09-20 |
CA2497788A1 (fr) | 2004-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1205748A1 (en) | Therapeutic epitopes and uses thereof | |
AU2003256253A8 (en) | Aerosol for medical treatment and methods | |
EP1509279A4 (fr) | Procede et methode de traitement de troubles cardiaques | |
EP1576033A4 (fr) | Procede permettant de produire des polysiloxanes et utilisation de ceux-ci | |
AU2003259717A8 (en) | Modulators of rabggt and methods of use thereof | |
HK1203216A1 (en) | Materials and methods for treating disorders of the ear | |
HUP0401808A3 (en) | Dosage forms, devices and methods of treatment | |
GB2389410B (en) | Lighter and method of use | |
EP1476150A4 (fr) | Carboxyfullerenes et procedes d'utilisation de ceux-ci | |
EP1567198A4 (fr) | Procedes et materiaux destines a traiter des troubles oculaires | |
EP1527196A4 (fr) | Traitement de l'asthme ou des allergies | |
GB2394672B (en) | Applicator and/or Stimulator Device | |
AU2003286737A8 (en) | Apparatuses and methods for the manufacture and placement of truss assemblies | |
EP1545507A4 (fr) | Therapie par l'activation de points de controle activee et ses procedes d'utilisation | |
EP1518925A4 (fr) | Cristal de la proteine de glucokinase et procede d'elaboration de medicament au moyen dudit cristal | |
GB0615918D0 (en) | Composition and its therapeutic use | |
EP1545596A4 (fr) | Utilisation de modulateurs du recepteur h4 de l'histamine pour le traitement des allergies et de l'asthme | |
GB0207410D0 (en) | Compounds and their therapeutic use | |
GB0128674D0 (en) | Treatment of sleep disorders and the like | |
AU2001249262A1 (en) | Therapeutic compounds for the treatment of asthma and allergy, and methods of use thereof | |
AU2003262229A1 (en) | Preventive and/or therapeutic drugs for asthma | |
AU2003250831A1 (en) | Use of hec1 antagonists in the treatment of proliferative disorders and cancer | |
AU2003223094A1 (en) | Hand held device for inhalation therapy and method of use thereof | |
AU2003259689A1 (en) | 3-imino-2-indolones for the treatment of depression and/or anxiety | |
GB0207409D0 (en) | Benzofuran-2H-3-one compounds and their therapeutic use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20050405 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20051115 |
|
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7G 01N 33/53 B Ipc: 7C 07K 16/00 B Ipc: 7A 61K 47/00 B Ipc: 7A 61K 39/00 A |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: THURMOND, ROBIN, L. Inventor name: LING, PING Inventor name: LEUNG, WAI-PING Inventor name: KARLSSON, LARS Inventor name: HOFSTRA, CLAUDIA, L. Inventor name: DUNFORD, PAUL, J. Inventor name: DESAI, PRAGNYA, J. |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20070305 |